Genelux (GNLX) Accounts Payables (2022 - 2026)
Genelux (GNLX) recorded quarterly Accounts Payables of $6.1 million in Q1 2026, up 39.86% quarter-over-quarter from $4.4 million in Q4 2025.
Genelux (GNLX) Accounts Payables (2022 - 2026) Analysis & Trends
Genelux's Accounts Payables history runs 5 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Accounts Payables changed N/A year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (changed N/A YoY), while the FY2025 annual figure was $4.4 million, down 21.76% from the prior year.
- Accounts Payables was $6.1 million for Q1 2026 at Genelux, up from $4.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $6.8 million in Q4 2022 to a low of $3.8 million in Q4 2023.
- Historically, Accounts Payables has averaged $5.0 million across 5 years, with a median of $4.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables slumped 44.15% in 2023, then jumped 47.2% in 2024.
- A 5-year view of Accounts Payables shows it stood at $6.8 million in 2022, then slumped by 44.15% to $3.8 million in 2023, then jumped by 47.2% to $5.6 million in 2024, then declined by 21.76% to $4.4 million in 2025, then jumped by 39.86% to $6.1 million in 2026.
- The last three Accounts Payables figures came in at $6.1 million (Q1 2026), $4.4 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Dec 31, 2024 | 5.57 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Dec 31, 2022 | 6.78 Mn |